Granules India gets approval for Potassium Chloride ER Capsules USP

17 Feb 2021 Evaluate

Granules India has declared that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg). It is bioequivalent to the reference listed drug product (RLD), Micro-K Extended-Release Capsules, 8 mEq and 10 mEq, of Nesher Pharmaceuticals (USA) LLC. The product would be manufactured at Hyderabad facility and is expected to be launched shortly.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

611.90 13.35 (2.23%)
01-Jan-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.05
Dr. Reddys Lab 1253.70
Cipla 1502.90
Zydus Lifesciences 909.80
Lupin 2088.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×